ABSTRACT: Liposomes incorporating porphyrin−phospholipid (PoP) can be formulated to release entrapped contents in response to nearinfrared (NIR) laser irradiation. Here, we examine effects of chelating copper or zinc into the PoP. Cu(II) and Zn(II) PoP liposomes, containing 10 molar % HPPH-lipid, exhibited unique photophysical properties and released entrapped cargo in response to NIR light. CuPoP liposomes exhibited minimal fluorescence and reduced production of reactive oxygen species upon irradiation. Zn-PoP liposomes retained fluorescence and singlet oxygen generation properties; however, they rapidly self-bleached under laser irradiation. Compared to the free base form, both Cu-and Zn-PoP liposomes exhibited reduced phototoxicity in mice. When loaded with mitoxantrone and administered intravenously at 5 mg/kg to mice bearing human pancreatic cancer xenografts, synergistic effects between the drug and the light treatment (for this particular dose and formulation) were realized with metallo-PoP liposomes. The drug-light-interval affected chemophototherapy efficacy and safety.
■ INTRODUCTION
An ongoing goal of drug delivery systems is to deliver therapeutic payloads while reducing the total exposure of the drug to healthy tissues and organs. To this end, nanoparticles such as liposomes have shown promise as delivery vehicles and have achieved several examples of clinical translation. 1−4 This success can often be attributed to modulation of pharmacokinetics, reduction of injected excipients, or reduction of negative side effects; as opposed to a straightforward improvement in therapeutic efficacy. 5 Most nanocarriers depend on passive accumulation at the diseased site, 5, 6 which is less than ideal. For this reason, strategies where nanoparticles are preferentially targeted to the diseased site have been explored, such as the use of prodrugs, antibody targeting, and external targeting. 7−11 As drug delivery vehicles, liposomes provide advantageous features such as biocompatibility, capacity for functionalization, reduction of side effects, and ability to encapsulate high amounts of drugs. 1, 12 Remote loading through transmembrane gradients enables the encapsulation of a variety of drugs at high concentrations including anticancer drugs such as doxorubicin (Dox) and mitoxantrone (MIT). 13 Both drugs have been used clinically in polyethylene glycol-coated (PEGylated) liposomes, and a liposomal Dox formulation has achieved clinical approval. 3 MIT has been evaluated in PEGylated liposomes in clinical trials. 14 Liposomes provide a way of reducing the side effects associated with these drugs, 15 thereby improving their efficacy. 12, 16 In theory, the use of external stimuli allows for precision treatment of a localized tumor and the potential to reduce the total injected drug dose. Such systems would involve the administration of a drug encapsulated in a nanoparticle, which can be activated by an external stimulus such as heat, light magnetic fields, or ultrasound. 17 While many types of drugloaded nanoparticles have been developed to respond to an external stimulus, thus far only one, a heat triggered doxorubicin liposomal formulation, has been tested in advanced clinical trials. 18, 19 We have previously shown that liposomes made with porphyrin−phospholipid (PoP) are capable of releasing cargo under laser irradiation, and drug release in the tumor may provide advantages over other triggering mechanisms. 20−22 Porphyrins have a long history of use in theranostic applications and are also being used for new approaches to photomedicine. 23, 24 In a previous study 20 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH)-lipid was added to a liposomal formulation consisting of distearoylphosphatidylcholine (DSPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(methoxy(PEG)-2000) (DSPE-PEG2K), and cholesterol (molar ratio 60:5:35) . It was shown that replacing 10% (molar) DSPC with 10% (molar) HPPH-lipid allowed the liposomes to release their contents when treated with a nearinfrared (NIR) laser. This liposomal formulation, when loaded with Dox was shown to be effective at ablating KB tumor xenografts with a single NIR chemophototherapy treatment. However, the liposome composition contained a relatively high amount of HPPH-lipid, meaning the amount of photosensitizer could be the dose-limiting factor. High photosensitizer doses can lead to two problems; phototoxicity under laser irradiation 25 and prolonged skin sunlight phototoxicity if the photosentizer is not rapidly cleared.
25−28 Skin toxicity might be increased in the case of PoP liposomes as the enhanced circulation time of PEGylated liposomes increases the accumulation of liposomes in the skin. 29, 30 One way to reduce phototoxic effects of the porphyrins is to chelate a metal such as Cu, 31, 32 which has been shown to quench singlet oxygen production. Metals have been shown to change functional and spectral properties of photosentizers and add novel functionality. 33−39 These include altering the cellular uptake, adding contrast agent functionality, or altering the photoactivity and efficacy. 40−42 Metallo-PoP liposomes in particular have been demonstrated to have unique properties and functions. When chelated with cobalt, PoP liposomes enable the binding of His-tag labeled proteins, 43 while the addition of 64 Cu and Mn allow the liposomes and other tetrapyrrolic nanoparticles to be readily used as PET and magnetic resonance imaging contrast agents. 44−47 To the best of our knowledge, metallo-PoP liposomes have not been evaluated for therapeutic activity.
Here, we demonstrate the effects of Cu and Zn chelation on the phototherapeutic properties of drug-loaded PoP liposomes. The use of metalloporphyrins in PoP liposomes is shown to change the spectral and functional characteristics of the liposomes. The addition of transition metals alters the photoreactive species generating capacities of the liposomes along with their cargo loading and release characteristics and behavior under NIR laser irradiation. The changes in these characteristics allow for in vivo applications, which would not be possible using equal dosing of the free base form of the PoP. Liposomes comprising 10 molar % free base HPPH-lipid, Cu-HPPH-lipid, and Zn-HPPH-lipid were evaluated for their photodynamic effects on tumor growth, and the therapeutic effects of using them to deliver antineoplastic drugs to tumors. It has been shown previously that a PDT treatment in conjunction with drug and nanoparticles enhances the tumor drug accumulation and provides a synergistic tumor growth inhibition effect. 48−53 Depending on the precise formulation, PoP liposomes function through combined effects of PDT, drug accumulation following light treatment, and the release of the drug from the liposomes following tumor accumulation. With this in mind, we have developed metallo-HPPH-lipids, which have the potential of reducing phototoxicity while retaining the therapeutic effects of PoP liposomes.
■ EXPERIMENTAL SECTION
HPPH-Lipid Synthesis and Liposome Preparation. HPPH-lipid was synthesized as previously described, 20 and metal chelation was accomplished as recently described, but using HPPH-lipid in place of pyro-lipid. 43 Cu-PoP was synthesized by combining free base HPPH PoP with 10 excess folds of anhydrous copper(II) acetate dissolved in 4 mL of tetrahydrofuran. The mixture was left in dark for 3 h with stirring. Similarly Zn-PoP was synthesized in the same manner with 10 excess folds of zinc(II) acetate dihydrate in 4 mL of methanol. The mixture was left in dark overnight with stirring. Reaction progress could be monitored by sampling small volumes and subjecting these to silica gel thin layer chromatography with a mobile phase with a volume ratio of [chloroform/methanol/water]; [65:25:4]. The solvent was removed by rotary evaporation, and the residue was extracted by chloroform/methanol/water 1:1.8:1 (volume ratio) three times. The chloroform layer was collected, the solvent was removed by rotary evaporation, and the product was freezedried to give a fine powder.
Liposomes were prepared either by the thin film hydration method (smaller scale) or by the hot ethanol injection method (larger scales). Lipid films were prepared by drying chloroform solutions containing DSPC (Avanti, # 850365P), DSPE-PEG2K (Avanti, # 880120P), HPPH−lipid (free base or metal chelated derivatives) and cholesterol (Avanti, # 700000P) in the molar ratios of 50:5:10:35 (DSPC/DSPE/DSPE-PEG2K/HPPH-lipid/Chol) under an argon stream. The films were kept overnight under vacuum to remove residual chloroform. To prepare liposomes, the films were rehydrated with phosphate-buffered saline (pH 7.4), producing a solution with a final lipid concentration of 10 mg/mL, and sonicated for 30 min at 60°C. Liposomes loaded with drugs were prepared by dissolving lipids at the indicated molar rations in ethanol at 60°C and adding ammonium sulfate for a final solution that is 20% ethanol v/v and a lipid concentration of 20 mg/mL. The solution was then extruded 10 times through stacked 80, 100, and 200 nm polycarbonate membranes. Following extrusion the liposomes were dialyzed overnight in a 10% sucrose buffer with 10 mM HEPES pH 7.4. The dialyzed liposomes were loaded with drugs at a lipid to drug molar ratio of 10:1 at 60°C for 30 min to 1 h. Loading efficacy was determined by separating unentrapped free drug from liposomes using a Sephadex G-75 (GE Heatlh) column (inclusion range up to 80 kDa), collecting 24, 1 mL fractions. Loading efficiency was calculated by comparing the drug fluorescence intensity of nonliposome fractions for a given sample pre-and postincubation. Drug fluorescence intensity was calculated by the area under the curve. Size and polydispersity were measured by dynamic light scattering in a NanoBrook 90 plus PALS in PBS. Zeta potential was measured in a 1 mM NaCl solution.
Spectral Experiments. Emission spectra were recorded for the three types of HPPH-lipid (Cu, Zn, and freebase) in methanol. Equal concentrations of each lipid were dissolved in methanol, and the emission spectra were recorded with an excitation of 400 nm using a PTI fluorimeter. For bleaching experiments, fluorescence measurements were taken before and after treatment with laser for intact and lysed (with 2.5% Triton-X100) liposomes. The laser treatment was conducted with a 665 nm laser at a fluence rate of 200 mW/cm 2 for 60 s in a 3 mL cuvette with stirring. Fluorescence measurements were done in a PTI fluorimeter with an excitation of 400 nm. Bleaching of the porphyrin was calculated by comparing the fluorescence of the HPPH-lipids at 665 nm post-laser to the pre-laser values of lysed liposomes. All liposomes were lysed to compare the total bleaching to an untreated sample, to avoid any effects, which may be induced by self-quenching. Absorbance measurements of liposomes were recorded for liposomes, which were laser treated identically to the fluorescence bleaching experiments. For consistency, all liposomes were lysed with 0.25% Triton X-100 before absorbance measurements were made.
Singlet Oxygen Generation. Singlet oxygen sensor green (SOSG, Molecular Probes, # S36002) was used to study the generation of singlet oxygen. Liposomes (5 nM PoP) were added to a 0.5 μM SOSG solution and irradiated at 200 mW/ cm 2 for 15 s. The fluorescence of SOSG was measured using excitation/emission of 504/525 nm before and after laser treatment. The fold increase was calculated by dividing the post-laser value by the pre-laser value.
Drug Release and Stability. Due to overlapping fluorescence wavelengths between HPPH and MIT, it was not possible to read the fluorescence of the MIT in the presence of HPPH. As a result, it was necessary to use a method for determining loading efficiency and laser triggered release. The most efficient way to do this was to run the laser treated liposomes over a Sephadex G-75 column. As we have previously shown the laser treatment permeabilizes the liposomes without destroying their structure, 20 it was possible to use G-75 columns to separate the liposomes from any free drug released during laser treatment. Liposomes were diluted in PBS and treated with a 665 nm laser for 10 min at a fluence rate of 200 mW/cm 2 . The treated liposomes were then run through a G-75 column to separate the free (released) drug from the drug still entrapped in the liposomes. Release was calculated by comparing the MIT fluorescence in nonliposome fractions to the fluorescence of an equal concentration of free MIT. Dox release was calculated by comparing the fluorescence before and after laser treatment and disruption with Triton X-100 using the equation (F fin − F int )/(F x100 − F int ) × 100%. Dox fluorescence was read with excitation/emission of 480/590 nm and MIT fluorescence at 607/688 nm in a Tecan plate reader. Serum stability was measured similarly to light release. Liposomes were incubated in 50% adult bovine serum at 37°C (Pel-Freez #37218−5) for 24 h, and drug release was assessed using fluorescence.
Survival Experiments. Animal experiments were carried out in accordance to protocols approved by the University at Buffalo Institutional Animal Care and Use Committee. . Tumor size was measured three times a week, and mice were sacrificed if the tumor grew larger than five times the initial volume or after 90 days.
In Vivo Imaging Experiments. For imaging experiments, nude mice bearing MIA-PaCa-2 tumors were injected with HPPH liposomes at a dose of 11 mg/kg HPPH-lipid (the equivalent of 5 mg/kg MIT). Twenty-four hours following injections (when the HPPH-lipid is partially unquenched and liposomes have extravasated into the skin), the mice were treated on the indicated locations and imaged before and after laser treatment with an IVIS imaging system (excitation, 665 nm filter; emission, Cy 5.5 filter). These results were confirmed with CD-1 mice (4 week females, Harlan Laboratories). Fur on the right flank on the mice was removed using clippers and hair removal cream. The mice were injected and treated as the nude mice. Similar results were observed in all treated mice (n = 3). The fluorescence bleaching was quantified by analyzing the treated spots using region of interest (ROI) analysis in the IVIS software.
Statistical Analysis. Kaplan−Meier survival curves were analyzed using Graphpad prism (Version 5.01) software. Each pair of groups were compared by Log-rank (Mantel−Cox) test. Differences were considered significant at p < 0.05. Median survival is defined as the time at which the staircase survival curve crosses the 50% survival point.
■ RESULTS AND DISCUSSION Liposome Photophysical Properties. Cu and Zn PoP were based on HPPH-phospholipid (synthesized as recently described 20 ), chelated with metals (carried out as recently described 43 ) at the center of the porphyrin ( Figure 1A ). These metallo-PoPs had greater than >90% purity based on HPLC ( Figure S1 in the Supporting Information). They were incorporated into liposomes containing DSPC/DSPE/DSPE-PEG2K/PoP/Cholesterol (molar ratio 50:5:10:35) and could be successfully formed using either hot ethanol injection and extrusion, or sonication. The chelation of metals into porphyrins is known to alter fluorescence and other properties. 54 Cu, for example, can attenuate the fluorescence, 55 which itself can be used as a proxy for the singlet oxygen generation capacity of the porphyrin. 56 Both Cu and Zn PoP liposomes exhibited reduced fluorescence compared to the metal free base PoP liposomes ( Figure 1B) . Cu-PoP liposomes showed more than a 95% reduction in fluorescence, while Zn-PoP liposomes showed only a slight decrease, which might be attributed to the rapid self-bleaching of the Zn porphyrin under ambient light.
Under laser irradiation, porphyrins eventually self-bleach due to reactions with the generated singlet oxygen, 57 a process that, to completely bleach the porphyrin, typically requires the application of large light doses. Zn-PoP liposomes had a very high rate of self-bleaching, compared to the free base and CuPoP ( Figure 1C) . When the three types of PoP liposomes derivatives were treated with a 665 nm laser for 60 s at 200 mW/cm 2 , the free base and Cu showed no significant bleaching in the lysed form and limited bleaching for intact liposomes. In contrast, the Zn had an almost complete reduction of its fluorescence. This self-bleaching was found to be more pronounced when the liposomes were lysed than when in the intact liposomal form. To study the effects of Cu (low fluorescence) and Zn (high self-bleaching) on HPPH-lipid singlet oxygen generation, the molecular probe singlet oxygen sensor green (SOSG) was used. As shown in Figure 1D , the free base in its lysed form generated significantly more singlet oxygen than any of the other samples. Cu did not induce a large increase in SOSG activity; however, the intact sample showed a greater increase than the lysed sample. Zn induced little increase in SOSG signal when intact and significantly more when lysed, as would be expected from the bleaching result. The self-bleaching of the Zn-PoP was accompanied by a reduction in the absorbance (Figure 2 ), which did not occur in the free base or Cu PoP liposomes treated under the same conditions. However, when treated for longer times the absorbance of both the free base and Cu also decreased, although they required significantly more time for results similar to that of the Zn. The mechanism of the photobleaching is unclear, but oxidative photobleaching is a well-known phenomenon observed for photosensitizers. 58 In Vivo Imaging. Nude mice were injected intravenously with equal doses of free base, Cu, and Zn PoP liposomes (11 mg/kg HPPH-lipid), and treated with a 665 nm laser for 12.5 min at 200 mW/cm 2 (150 J/cm 2 ) 24 h following injection, when the HPPH is unquenched. Mice were imaged before and after laser treatment. The laser treatment induced limited bleaching in the mice injected with the free base and complete bleaching at the treated location in the mice injected with Zn ( Figure 3 ). Cu-PoP liposome treated mice did not show any significant fluorescence in either pre-or post-laser images. ROI analysis of similarly treated CD-1 mice showed a 3-fold decrease in fluorescence of the free base group, a 7-fold decrease for the Zn group, and no significant difference between in Cu group ( Figure S2 in the Supporting Information).
Drug Loading and Stability. It has previously been shown that liposomes containing PoP can actively load drugs such as doxorubicin when the formulation contains a type of PoP that can form a stable bilayer with the appropriate phospholipid composition. 20, 59 Doxorubicin can be stably loaded into liposomes consisting of 10% (molar) free base HPPH-lipid. 20 Metalloporphyrins were able to form liposomes with similar characteristics as the free base PoP ( Figure S3 in the Supporting Information). However, Dox proved difficult to stably load consistently into metal-PoP liposomes. For this reason we explored the use of another drug, mitoxantrone (MIT), an anthraquinone that can be actively loaded into liposomes. 16, 60 Liposomes loaded with MIT showed high (>90%) loading efficiencies, while liposomes loaded with Dox showed lower and inconsistent loading ( Figure 4A ). The effect of the metals on the stability of the liposomes was studied assessed in 50% serum at 37°C. MIT loaded liposomes had the greatest stability with less than 10% release for free base and less than 25% for Cu and Zn PoP after 24 h. Free base Doxloaded PoP liposomes were stable, however, both Cu and Zn Dox-loaded PoP liposomes were not, with more than 90% drug release ( Figure 4B ). The effects of the metals on light triggered release was tested for both Dox and MIT liposomes treated for 10 min at 200 mW/cm 2 ( Figure 4C ). Both free base and Zn showed more than 85% release following light treatment. In the case of Cu, very little release was observed immediately after light treatment. However, over time Dox was slowly released up to 2 h following light treatment ( Figure 4D) .
In Vivo Efficacy. MIT-loaded PoP liposomes were used for in vivo experiments. Mice were injected with 5 mg/kg MIT PoP liposomes and treated either 10 min or 24 h following IV injection at a fluence rate of 200 mW/cm 2 for 12.5 min (150 J/ cm 2 ). Mice treated at a 10 min drug−light interval following injection showed delay in tumor growth for both empty and loaded liposomes compared to saline (median survival = 12 days) ( Figure 5 ). The groups treated with free base PoP showed no significant differences between the loaded and empty liposome treatments (median survival = 38 days for both). Cu-PoP loaded and empty (21 vs 19 days) and Zn-PoP loaded and empty (35 vs 21 days) liposome groups showed statistically significant differences between the treatments with or without MIT (P < 0.05).
The mice that were treated at a 24 h drug−light interval also exhibited delayed tumor growth, with the striking exception of mice treated with the free base PoP, which had to be sacrificed due to severe phototoxicity induced by the light treatment ( Figure 6 ). The Cu-PoP (MIT-loaded and empty; 19 and 17 . Mice were given a single injection and phototreatment and sacrificed when the tumor size was greater than five times the initial volume. Based on the log-rank test there was a statistically significant difference between all treatment groups and the saline control (P < 0.05). There were no statistically significant differences between the empty and mitoxantrone loaded free base liposomes. There were statistically significant differences between the empty and loaded Cu and Zn HPPH-lipid liposomes (P < 0.05).
days median survival, respectively) groups showed a significant (P < 0.05) survival improvement compared to the saline group, as did the Zn-PoP (MIT-loaded and empty; 43 and 38 days median survival). However, there was no significant difference in survival with phototreatments using the MIT-loaded and empty metallo-PoP liposomes at the 24 h drug−light interval. The lack of differences between the loaded and empty liposome can be attributed to either lower circulating drug concentrations, a stronger PDT effect at 24 h due to tumor uptake and unquenching, or a combination of both. Of all the groups, those treated with Zn-PoP at 24 h showed the greatest increase in survival time, followed closely by free base treated at 10 min. Groups treated with Cu-PoP showed similar results for treatments done at 10 min and 24 h, suggesting the efficacy is due to a mild PDT effect rather than a drug-induced effect. Similarly, the treatment of Zn-PoP at 24 h shows that a PDT effect is the dominant factor contributing to its efficacy, whereas the treatments done at 10 min, which showed a significant difference between the MIT-loaded and empty groups, suggests that at the right dose of drug-loaded liposomes can have greater efficacy as has been shown previously. 20, 21 Metallo-PoP liposomes demonstrated unique properties, which may make their use advantageous compared to the free base form in certain circumstances. The inclusion of either Cu or Zn improved the safety of the liposomes while maintaining the liposomes ability to function as a therapeutic and drug delivery agent. While the addition of the metals reduced the therapeutic efficacy compared to the freebase at a MIT dose of 5 mg/kg, higher doses may have allowed the ZnPoP to be equally as effective, as demonstrated in pilot studies using 10 mg/kg ( Figure S4 in the Supporting Information). Cu-PoP significantly reduced the singlet oxygen generating capacity of the liposomes, rendering them safer than the other variations tested. With limited singlet oxygen generation, CuPoP liposomes did not provide sufficient therapeutic effectiveness in the formulations tested since these likely relied on a photodynamic effect to permeabilize tumor vasculature and enhance liposome accumulation, a phenomena known to occur when PDT treatment is used with nanoparticles 48, 53 and plays a key role in the efficacy of PoP liposomes. Zn-PoP liposomes retained the capacity to induce permeabilization of tumor vasculature and could be effective at enhancing the delivery of drugs to the target site, while minimizing the potential for phototoxic reactions. The free base form was safe when used immediately following injection but not 24 h postinjection. This can be attributed to the fact that the HPPH is quenched when the liposomes are intact (as they are during the early time points following injection), as is the singlet oxygen generation of the HPPH-lipid. 56 Over time, the HPPH fluorescence is unquenched in the blood and in organs where the liposomes have accumulated as they are broken down. The use of Zn-HPPH-lipid solves this problem as it rapidly selfbleaches under laser irradiation when the liposomes are unquenched thereby reducing potential for phototoxicity. This was clearly demonstrated in the groups treated at 24 h. The free base showed significant toxicity, which made the treatment fatal, whereas the Zn-PoP groups showed no signs of phototoxicity and improved tumor growth suppression compared to the Zn-PoP groups treated at 10 min postinjection.
Unlike our previously published results showing a strong synergistic effect between the drug and phototreatment for Dox-loaded free base PoP liposomes, 20, 21 MIT PoP liposomes with this particular formulation behaved differently. While the benefits of the drug loaded liposomes shown here were relatively modest, they could be seen in the Zn-PoP liposome groups treated at 10 min. Higher drug doses may help to provide greater survival in groups treated with the drug while not significantly increasing the effect of the empty liposomes. The combination of the high photosensitizer and light doses used in this treatment would likely lead to oxygen depletion. 61 Increasing the drug dose may improve the tumor drug accumulation and consequently its efficacy.
Metallo-PoP liposomes demonstrated unique properties, which may have applications in reducing the toxicities associated with the use of the free base porphyrins. Zn HPPH-lipid provided a reduction in phototoxicity through its rapid self-bleaching properties while maintaining an antitumor effect. While Cu HPPH-lipid demonstrated the ability to reduce singlet oxygen generation, it also showed less favorable therapeutic efficacy, demonstrating that for this treatment with this particular formulation, a photodynamic effect was beneficial. However, Cu-PoP might be appropriate to induce release of cargo in extravasated liposomes to improve drug efficacy without photodynamic effect, although the suitability of Cu-PoP for this such an application requires further study at higher drug doses. Both metal forms of HPPH-lipid demonstrated the ability to provide a therapeutic benefit and with modifications and additional development could be used to deliver antitumor drugs in light-triggered liposomes with . Mice were given a single injection and laser treatment and were sacrificed when the tumor size was greater than five times the initial volume. Mice treated with the free base were all sacrificed within 24 h of the treatment due to a reduction in body temperature or severe lethargy. Based on the log-rank test there was a statistically significant difference between both Cu and Zn groups and the saline control (P < 0.05). However, there was no significant differences between the mitoxantrone loaded and empty liposomes.
diminished phototoxicity associated with the use of photosensitizers.
■ CONCLUSION
The use of metallo-PoP liposomes imparts unique properties, which have been demonstrated to affect the photoreactivity of the liposomes when used as a delivery system for anticancer drugs. The improved safety may allow for future applications in which the use of large amounts of the free base form of the PoP would not be feasible due to risks of phototoxicity. Cu-PoP liposomes hold potential to be used for drug delivery based on mechanisms solely related to triggered release. Zn-PoP liposomes might be used for drug delivery based both on tumor vascular damage and drug-releasing mechanisms, together with photosensitization with a self-limiting capacity for phototoxicity.
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